Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

New England Journal of Medicine

Volumn 346, Issue 21, 2002, Pages 1623-1630

  Cummings, David E ^a,c   Weigle, David S ^a,d   Scott Frayo, R ^a,c   Breen, Patricia A ^a,d   Ma, Marina K ^a,c   Patchen Dellinger, E ^b,e   Purnell, Jonathan Q ^f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e University Hospital

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN; LEPTIN;

ADULT; APPETITE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY WEIGHT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; MALE; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; APPETITE REGULATION; BODY COMPOSITION; CIRCADIAN RHYTHM; DIET, REDUCING; FEMALE; GASTRIC BYPASS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; PEPTIDES; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 0037162116     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa012908     Document Type: Article

References (43)

1. As obesity rates rise, experts struggle to explain why
2. Obesity as a medical problem
3. Mortality and weight: Insured lives and the American Cancer Society Studies
4. Changes in energy expenditure resulting from altered body weight
5. Central nervous system control of food intake
6. Medicinal strategies in the treatment of obesity
7. Diet, behavior modification, and exercise: A review of obesity treatments from a long-term perspective
8. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: A five-year perspective
9. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
10. Sibutramine produces dose-related weight loss
11. Current status of medical and surgical therapy for obesity
12. Evaluation of health status and quality of life after bariatric surgery: Comparison of standard Roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding
13. Weight loss and food intake 18 months following vertical banded gastroplasty or gastric bypass for severe obesity
14. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty
15. Physiological satiety implications of gastrointestinal antiobesity surgery
16. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
17. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans
18. Ghrelin induces adiposity in rodents
19. A role for ghrelin in the central regulation of feeding
20. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion
21. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
22. Ghrelin causes hyperphagia and obesity in rats
23. Ghrelin enhances appetite and increases food intake in humans
24. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
25. Popular weight loss diets: Health and exercise implications
26. Quantitative estimation of insulin sensitivity
27. A method for underwater weighing and determination of body density
28. Abnormal body fat distribution detected by computed tomography in diabetic men
29. Morphological changes in the adipocyte during fat deposition and mobilization
30. Immunoassay of insulin: Two antibody system: Plasma insulin levels of normal, subdiabetic and diabetic rats
31. Circulating ghrelin levels are decreased in human obesity
32. Appetitive behavior after gastric bypass for obesity
33. Eating behavior after gastric bypass surgery for obesit
34. Quality of life after gastric bypass for morbid obesity
35. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass
36. Gastric bypass versus gastroplasty: A prospective study of differences in two surgical procedures for morbid obesity
37. Gastric bypass and vertical banded gastroplasty - A prospective randomized comparison and 5-year follow-up
38. The effectiveness of gastric bypass over gastric partition in morbid obesity: Consequence of distal gastric and duodenal exclusion
39. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters
40. Swedish obese subjects (SOS): An obesity intervention study with a nutritional perspective
41. Morbid obesity
42. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone
43. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH: Evidence for somatotroph desensitization independent of GH pool depletion